NEW YORK, N.Y.
Medidata Solutions, a global provider of hosted clinical development solutions, announced a multi-year contract extension with Bristol-Myers Squibb Company for use of Medidata Grants Manager™, an investigator site benchmarking tool that helps sponsors ensure fair and consistent investigator payments, mitigate compliance risks and reduce trial start-up time. Under this new contract, Bristol-Myers Squibb will also be expanding its use of Grants Manager to include analysis and contracting modules.
Bristol-Myers Squibb has used Grants Manager for 15 years. Powered by the PICAS® clinical cost database of negotiated agreements between sponsors and investigators, Grants Manager provides access to key fair market value data of investigator costs and payments. The Grants Manager solution enables clinical teams to facilitate clinical cost planning and budgeting processes and create consensus in the budget review and approval process. The analysis tool offers access to reporting on trial financial data, while the contracting module enables collaborative review of budgets via the Internet to further streamline the company’s processes.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.